Abstract
While research concerning brain structural biomarkers of major depressive disorder (MDD) is continuously progressing, our state of knowledge regarding biomarkers of specific clinical profiles of MDD is still limited. The aim of the present study was to investigate brain structural correlates of social anhedonia as a cardinal symptom of MDD. In a cross-sectional study, we investigated n = 166 patients with MDD and n = 166 matched healthy controls (HC) using structural magnetic resonance imaging (MRI). Social anhedonia was assessed using the Chapman Scales for Social Anhedonia (SAS). An anhedonia x group ANCOVA was performed in a region of interest approach of the dorsal and ventral striatum (bilateral caudate nucleus, putamen, nucleus accumbens respectively) as well as on whole-brain level. The analyses revealed a significant main effect for social anhedonia: higher SAS-scores were associated with reduced gray matter volume in the bilateral caudate nucleus in both the MDD-group (pFWE = 0.002) and the HC-group (pFWE = 0.032). The whole-brain analysis confirmed this association (left: pFWE = 0.036, right: pFWE = 0.047). There was no significant main effect of group and no significant anhedonia x group interaction effect. This is the first study providing evidence for volumetric aberrations in the reward system related to social anhedonia independently of diagnosis, depression severity, medication status, and former course of disease. These results support the hypothesis that social anhedonia has a brain biomarker serving as a possible endophenotype of depression and possibly providing an alternative approach for a more precise and effective treatment.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223.
Wittchen H-U, Jacobi F. Size and burden of mental disorders in Europe - A critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15:357–76.
Arnone D, McIntosh AM, Ebmeier KP, Munafò MR, Anderson IM. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropsychopharmacol. 2012;22:1–16.
Bora E, Fornito A, Pantelis C, Yücel M. Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord. 2012;138:9–18.
Redlich R, Opel N, Bürger C, Dohm K, Grotegerd D, Förster K, et al. The limbic system in youth depression: brain structural and functional alterations in adolescent in-patients with severe depression. Neuropsychopharmacology. 2018;43:546–54.
Stuhrmann A, Suslow T, Dannlowski U. Facial emotion processing in major depression: a systematic review of neuroimaging findings. Biol Mood Anxiety Disord. 2011;1:1–17.
Suslow T, Konrad C, Kugel H, Rumstadt D, Zwitserlood P, Schöning S, et al. Automatic mood-congruent amygdala responses to masked facial expressions in major depression. Biol Psychiatry. 2010;67:155–60.
Redlich R, Almeida JR, Grotegerd D, Opel N, Kugel H, Heindel W, et al. Brain morphometric biomarkers distinguishing unipolar and bipolar depression: a voxel-based morphometry-pattern classification approach. JAMA Psychiatry. 2014;71:1222–30.
Redlich R, Opel N, Grotegerd D, Dohm K, Zaremba D, Burger C, et al. Prediction of individual response to electroconvulsive therapy via machine learning on structural magnetic resonance imaging data. JAMA Psychiatry. 2016;73:557–64.
Schmaal L, Hibar DP, Sämann PG, Hall GB, Baune BT, Jahanshad N, et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group. Mol Psychiatry. 2017;22:900–9.
Stratmann M, Konrad C, Kugel H, Krug A, Schöning S, Ohrmann P, et al. Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. PLoS One. 2014;9:e102692.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013.
Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol. 1976;85:374–82.
Pelizza L, Pupo S, Ferrari A. Anhedonia in schizophrenia and major depression: state or trait? Review of the literature. J Psychopathol. 2012;18:145–55.
Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes for major depression. Neuropsychopharmacology. 2004;29:1765–81.
McMakin DL, Olino TM, Porta G, Dietz LJ, Emslie G, Clarke G, et al. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatmentresistant depression. J Am Acad Child Adolesc Psychiatry. 2012;51:404–11.
Spijker J, Bijl RV, Graaf R, de, Nolen WA. Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand. 2001;103:122–30.
Harvey PO, Pruessner J, Czechowska Y, Lepage M. Individual differences in trait anhedonia: a structural and functional magnetic resonance imaging study in non-clinical subjects. Mol Psychiatry. 2007;12:767–75.
Keller J, Young CB, Kelley E, Prater K, Levitin DJ, Menon V. Trait anhedonia is associated with reduced reactivity and connectivity of mesolimbic and paralimbic reward pathways. J Psychiatr Res. 2013;47:1319–28.
Wacker J, Dillon DG, Pizzagalli DA. The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. Neuroimage. 2009;46:327–37.
Auerbach RP, Pisoni A, Bondy E, Kumar P, Stewart JG, Yendiki A, et al. Neuroanatomical prediction of anhedonia in adolescents. Neuropsychopharmacology. 2017;42:2087–95.
Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R, et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated subjects with major depressive disorder. Am J Psychiatry. 2009;166:702–10.
Epstein J, Pan H, Kocsis JH, Yang Y, Butler T, Chusid J, et al. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry. 2006;163:1784–90.
Keedwell P, Andrew C, Williams SCR, Brammer MJ, Phillips ML. The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry. 2005;58:843–53.
Stuhrmann A, Dohm K, Kugel H, Zwanzger P, Redlich R, Grotegerd D, et al. Mood-congruent amygdala responses to subliminally presented facial expressions in major depression: associations with anhedonia. J Psychiatry Neurosci. 2013;38:249–58.
Vakili K, Pillay SS, Lafer B, Fava M, Renshaw PF, Bonello-Cintron CM, et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry. 2000;47:1087–90.
Arnone D, McKie S, Elliott R, Juhasz G, Thomas EJ, Downey D, et al. State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry. 2013;18:1265–72.
Zaremba D, Dohm K, Redlich R, Grotegerd D, Strojny R, Meinert S, et al. Association of brain cortical changes with relapse in patients with major depressive disorder. JAMA Psychiatry. 2018a;75:484–92.
Zaremba D, Enneking V, Meinert S, Förster K, Bürger C, Dohm K et al. Effects of cumulative illness severity on hippocampal gray matter volume in major depression: a voxel-based morphometry study. Psychol Med 2018b;48: 1–8.
Dannlowski U, Kugel H, Grotegerd D, Redlich R, Suchy J, Opel N, et al. NCAN cross-disorder risk variant is associated with limbic gray matter deficits in healthy subjects and major depression. Neuropsychopharmacology. 2015;40:2510–6.
Wittchen H-U, Wunderlich U, Gruschwitz S, Zaudig M. Strukturiertes Klinisches interview für DSM-IV: SKID. Achse I: Psychische Störungen. Interviewheft und Beurteilungsheft. Eine deutschsprachige, erweiterte Bearbeitung der amerikanischen Originalversion des SCID-I. Göttingen: Hogrefe; 1997.
Burgdörfer G, Hautzinger M. Physische und soziale Anhedonie - Die Evaluation eines Forschungsinstruments zur Messung einer psychopathologischen Basisstörung. Eur Arch Psychiatry Neurol Sci. 1987;236:223–9.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
Redlich R, Dohm K, Grotegerd D, Opel N, Zwitserlood P, Heindel W, et al. Reward processing in unipolar and bipolar depression: a functional MRI study. Neuropsychopharmacology. 2015;40:2623–31.
Dannlowski U, Stuhrmann A, Beutelmann V, Zwanzger P, Lenzen T, Grotegerd D, et al. Limbic scars: long-term consequences of childhood maltreatment revealed by functional and structural magnetic resonance imaging. Biol Psychiatry. 2012;71:286–93.
Opel N, Zwanzger P, Redlich R, Grotegerd D, Dohm K, Arolt V, et al. Differing brain structural correlates of familial and environmental risk for major depressive disorder revealed by a combined VBM/pattern recognition approach. Psychol Med. 2016;46:277–90.
Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19:1233–9.
Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273–89.
Alemán-Gómez Y, Melie-Garcia L, Valdes-Hernandez P. IBASPM: toolbox for automatic parcellation of brain structures. 12th Annual Meeting of the Organization for Human Brain Mapping. June 11–15, 2006. Florence, Italy. 2006.
Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35:537–55.
Haruno M, Kuroda T, Kenji D, Toyama K, Kimura M, Samejima K, et al. A neural correlate of reward-based behavioral learning in caudate nucleus: a functional magnetic resonance imaging study of a stochastic decision task. J Neurosci. 2004;24:1660–65.
Goldstein BL, Klein DN. A review of selected candidate endophenotypes for depression. Clin Psychol Rev. 2014;34:417–27.
Pan PM, Sato JR, Salum GA, Rohde LA, Gadelha A, Zugman A, et al. Ventral striatum functional connectivity as a predictor of adolescent depressive disorder in a longitudinal community-based sample. Am J Psychiatry. 2017;174:1112–9.
McCabe C, Cowen PJ, Harmer CJ. Neural representation of reward in recovered depressed patients. Psychopharmacol (Berl). 2009;205:667–77.
Ebdrup BH, Glenthøj B, Rasmussen H, Aggernaes B, Langkilde AR, Paulson OB, et al. Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia. J Psychiatry Neurosci. 2010;35:95–104.
Robinson D. Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52:393.
Jurgens CK, Van De Wiel L, Van Es AC, Grimbergen YM, Witjes-Ané MN, Van Der Grond J, et al. Basal ganglia volume and clinical correlates in “preclinical” Huntington’s disease. J Neurol. 2008;255:1785–91.
Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology. 2005;64:224–9.
Nilsson FM, Kessing LV, Sorensen TM, Andersen PK, Bolwig TG. Major depressive disorder in Parkinson’s disease: a register-based study. Acta Psychiatr Scand. 2002;106:202–11.
Dichter GS, Felder JN, Petty C, Bizzell J, Ernst M, Smoski MJ. The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry. 2009;66:886–97.
Yoshimura S, Okamoto Y, Onoda K, Matsunaga M, Okada G, Kunisato Y, et al. Cognitive behavioral therapy for depression changes medial prefrontal and ventral anterior cingulate cortex activity associated with self-referential processing. Soc Cogn Affect Neurosci. 2014;9:487–93.
Buchheim A, Viviani R, Kessler H, Kächele H, Cierpka M, Roth G et al. Changes in prefrontal-limbic function in major depression after 15 months of long-term psychotherapy. PLoS ONE. 2012;7:e33745.
Haq AU, Sitzmann AF, Goldman ML, Maixner DF, Mickey BJ. Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry. 2015;76:1374–84.
Wade BS, Joshi SH, Njau S, Leaver AM, Vasavada M, Woods RP, et al. Effect of electroconvulsive therapy on striatal morphometry in major depressive disorder. Neuropsychopharmacology. 2016;5:1–30.
Das D, Cherbuin N, Anstey KJ, Sachdev PS, Easteal S. Lifetime cigarette smoking is associated with striatal volume measures. Addict Biol. 2012;17:817–25.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Enneking, V., Krüssel, P., Zaremba, D. et al. Social anhedonia in major depressive disorder: a symptom-specific neuroimaging approach. Neuropsychopharmacol. 44, 883–889 (2019). https://doi.org/10.1038/s41386-018-0283-6
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41386-018-0283-6
This article is cited by
-
The characteristics of anhedonia in depression: a review from a clinically oriented perspective
Translational Psychiatry (2025)
-
Understanding the interplay of autistic traits, depression and suicidal ideation in adolescents with major depressive disorder
Scientific Reports (2025)
-
Altered brain structure age gap estimation in major depressive disorder patients with and without anhedonia: a machine learning-based study
Translational Psychiatry (2025)
-
Social Anhedonia: (f)MRI Studies
Neuroscience and Behavioral Physiology (2023)
-
Anhedonia in Depression: Neurobiological and Genetic Aspects
Neuroscience and Behavioral Physiology (2022)
